Sanolium successfully announces results from the tender offer
NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS MAY BE RESTRICTED BY LAW
Sanolium AB (publ) (the “Company” or “Sanolium”), being the parent company of the Cambio group, announces results of its tender offer (the “Tender Offer”) to the holders of Sanolium’s existing SEK 800 million bonds under the 2019/2024 senior secured bond framework with ISIN SE0012596179 (the “Existing Bonds”).
As informed by the Company in a press release dated 7 March 2024, the Company has successfully issued senior secured bonds (the “New Bonds”) in an initial amount of SEK 1,000 million under a total framework of SEK 1,500 million.
The Tender Offer expired at 12:00 CET on 7 March 2024. Sanolium will repurchase Existing Bonds in an aggregate amount of SEK 528.75 million. The price for the Existing Bonds accepted for purchase in the Tender Offer amounts to 100 per cent. of the nominal amount per Existing Bond plus accrued and unpaid interest from, but excluding, the previous interest payment date to, and including, the settlement date for the Tender Offer. Settlement for the Tender Offer is expected to occur on or around 15 March 2024.
In accordance with Sanolium’s conditional notice of early redemption of the Existing Bonds published on 29 February 2024, Sanolium intends, subject to the conditions therein being fulfilled, to exercise its right of early redemption. Upon such early redemption, the Existing Bonds will be repurchased at a price corresponding to 100.00 per cent. of the nominal amount plus accrued and unpaid interest from each person who is registered as owner of Existing Bonds as of the record date, being 19 March 2024, and the settlement date for the early redemption is expected to occur on 26 March 2024.
DNB Markets, a part of DNB Bank ASA, Sweden Branch (“DNB”) acted as sole global coordinator and joint bookrunner and Carnegie Investment Bank AB (“Carnegie”) as joint bookrunner of the issuance of the New Bonds. DNB and Carnegie further acted as dealer managers in connection with the Tender Offer. Advokatfirman Cederquist acted as legal advisor to the joint bookrunners and Roschier Advokatbyrå acted as legal advisor to the Company.
For further information, please contact:
Rami Avidan, CEO, Cambio
+46 070 793 483
rami.avidan@cambio.se
Johannes Fabó, CFO, Cambio
+46 730 599 368
Johannes.fabo@cambio.se
Jenny Styren, Chief Marketing & Communications Officer, Cambio
+46 703 793 483
jenny.styren@cambio.se
About the Company:
Sanolium AB, parent of the Cambio Group (“Cambio” or the “Company”) operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia with more than 200,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.